These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23913157)

  • 1. Risk-based scientific approach for determination of extractables/leachables from biomanufacturing of antibody-drug conjugates (ADCs).
    Ding W
    Methods Mol Biol; 2013; 1045():303-11. PubMed ID: 23913157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
    Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
    PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis and evaluation of single-use bag extractables for validation in biopharmaceutical applications.
    Pahl I; Dorey S; Barbaroux M; Lagrange B; Frankl H
    PDA J Pharm Sci Technol; 2014; 68(5):456-71. PubMed ID: 25336417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 1-Introduction to Errors in Chromatographic Screening for Organic Extractables and Leachables and Discussion of the Errors of Omission.
    Christiaens P; Beusen JM; Verlinde P; Baeten J; Jenke D
    PDA J Pharm Sci Technol; 2020; 74(1):90-107. PubMed ID: 31209164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practices for extractables and leachables in orally inhaled and nasal drug products: an overview of the PQRI recommendations.
    Norwood DL; Paskiet D; Ruberto M; Feinberg T; Schroeder A; Poochikian G; Wang Q; Deng TJ; DeGrazio F; Munos MK; Nagao LM
    Pharm Res; 2008 Apr; 25(4):727-39. PubMed ID: 18183477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing relative response factor variation using a multidetector approach for extractables and leachables (E&L) analysis to mitigate the need for uncertainty factors.
    Jordi MA; Rowland K; Liu W; Cao X; Zong J; Ren Y; Liang Z; Zhou X; Louis M; Lerner K
    J Pharm Biomed Anal; 2020 Jul; 186():113334. PubMed ID: 32387747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of safety qualification thresholds and their use in orally inhaled and nasal drug product evaluation.
    Ball D; Blanchard J; Jacobson-Kram D; McClellan RO; McGovern T; Norwood DL; Vogel W; Wolff R; Nagao L
    Toxicol Sci; 2007 Jun; 97(2):226-36. PubMed ID: 17369604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical and bioanalytical technologies for characterizing antibody-drug conjugates.
    Alley SC; Anderson KE
    Curr Opin Chem Biol; 2013 Jun; 17(3):406-11. PubMed ID: 23570980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing safety of extractables from materials and leachables in pharmaceuticals and biologics - Current challenges and approaches.
    Broschard TH; Glowienke S; Bruen US; Nagao LM; Teasdale A; Stults CL; Li KL; Iciek LA; Erexson G; Martin EA; Ball DJ
    Regul Toxicol Pharmacol; 2016 Nov; 81():201-211. PubMed ID: 27569203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on the PQRI Extractables and Leachables "Safety Thresholds and Best Practices" Recommendations for Inhalation Drug Products.
    Norwood DL; Nagao LM; Stults CL
    PDA J Pharm Sci Technol; 2013; 67(5):413-29. PubMed ID: 24084658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry.
    Xu K; Liu L; Saad OM; Baudys J; Williams L; Leipold D; Shen B; Raab H; Junutula JR; Kim A; Kaur S
    Anal Biochem; 2011 May; 412(1):56-66. PubMed ID: 21216214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of UV-absorbing extractables from rubber closures used in containers of injectable powder and safety assessment of leachables in the drug.
    Wei Y; Wu Y; Zhu T; Li Z; Zhang Y
    J Pharm Biomed Anal; 2017 May; 138():256-266. PubMed ID: 28231528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP).
    Paskiet D; Jenke D; Ball D; Houston C; Norwood DL; Markovic I
    PDA J Pharm Sci Technol; 2013; 67(5):430-47. PubMed ID: 24084659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design.
    Martin-Moe S; Lim FJ; Wong RL; Sreedhara A; Sundaram J; Sane SU
    J Pharm Sci; 2011 Aug; 100(8):3031-3043. PubMed ID: 21425164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-Scale Assessment of Extractables and Leachables in Single-Use Bags for Biomanufacturing.
    Dorival-García N; Carillo S; Ta C; Roberts D; Comstock K; Lofthouse S; Ciceri E; D'Silva K; Kierans G; Kaisermayer C; Lindeberg A; Bones J
    Anal Chem; 2018 Aug; 90(15):9006-9015. PubMed ID: 29943976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extractables/leachables from plastic tubing used in product manufacturing.
    Jenke DR; Story J; Lalani R
    Int J Pharm; 2006 Jun; 315(1-2):75-92. PubMed ID: 16563675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extractables and leachables considerations for prefilled syringes.
    Jenke DR
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1591-600. PubMed ID: 24955780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Safety Risk-Based Extractables and/or Leachables Qualification Strategy for Packaged Drug Products.
    Jenke D
    PDA J Pharm Sci Technol; 2021; 75(6):506-535. PubMed ID: 33990423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of Chromatographic Screening Methods for Organic Extractables and Leachables by Managing Outcomes.
    Jenke D
    PDA J Pharm Sci Technol; 2023; 77(4):329-338. PubMed ID: 37001885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antibody-drug conjugates by mass spectrometry: advances and future trends.
    Huang RY; Chen G
    Drug Discov Today; 2016 May; 21(5):850-5. PubMed ID: 27080148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.